tiprankstipranks
Trending News
More News >

GeneDx price target lowered to $110 from $135 at TD Cowen

TD Cowen lowered the firm’s price target on GeneDx (WGS) to $110 from $135 and keeps a Buy rating on the shares. The firm noted the shares fell after reporting better than expected results and raising guidance. The TAM is largeand barely penetrated, execution has been solid, NICU ramp driving volumes is logical, and price/margins beat and Cowen sees upside.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue